Genome interpretation firm Omicia has hired Paul Billings as its new chief medical officer. Billings will also serve on the firm's scientific advisory board.
He comes to Omicia from Life Technologies, which was acquired by Thermo Fisher Scientific and where he was chief medical officer. Before that, Billings was chief scientific officer of the Genomic Medicine Institute at El Camino Hospital, and CEO of CELLective Dx Corporation. Billings is a genomics industry leader and has held executive-level positions at numerous top life sciences firms and organizations.